ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,1,Blood oestrogen increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
5,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,3,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
5,4,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,5,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10,5,Needle track marks,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
10,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
10,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
13,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
13,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
15,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
15,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
15,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
16,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
17,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
18,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
19,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
19,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
20,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
20,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
20,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
21,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
21,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
23,1,Burns fourth degree,Thermal burns,Injuries by physical agents,Inj&P,Y
23,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
24,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
25,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
25,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
27,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
28,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
28,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
28,5,Painful erection,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
28,6,Penile burning sensation,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
28,7,Penile curvature,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
28,8,Penile discharge,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
28,9,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
28,10,Physical disability,Disability issues,Lifestyle issues,SocCi,N
28,11,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
28,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
29,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
32,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
33,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
34,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
35,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
36,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
36,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
37,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
38,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
38,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
39,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
39,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
39,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
40,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
41,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
